Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,280 | 144 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $616.32 | 40 | $0 (2023) |
| Novo Nordisk Inc | $423.28 | 26 | $0 (2024) |
| Lilly USA, LLC | $327.22 | 23 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $276.07 | 17 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $108.83 | 6 | $0 (2023) |
| Merck Sharp & Dohme LLC | $94.68 | 6 | $0 (2023) |
| PFIZER INC. | $75.95 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $57.50 | 4 | $0 (2022) |
| Amgen Inc. | $49.76 | 3 | $0 (2024) |
| SANOFI PASTEUR INC. | $37.41 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $153.67 | 8 | Amgen Inc. ($49.76) |
| 2023 | $708.16 | 41 | GlaxoSmithKline, LLC. ($188.93) |
| 2022 | $596.63 | 41 | GlaxoSmithKline, LLC. ($183.54) |
| 2021 | $341.50 | 24 | GlaxoSmithKline, LLC. ($151.10) |
| 2020 | $362.01 | 23 | AstraZeneca Pharmaceuticals LP ($132.76) |
| 2019 | $117.79 | 7 | AstraZeneca Pharmaceuticals LP ($56.23) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardiology | ||||||
| 10/09/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $33.48 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/14/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: WOMENS HEALTH | ||||||
| 07/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Diabetes | ||||||
| 05/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Diabetes Care | ||||||
| 03/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Inflammation | ||||||
| 11/16/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Gastroenterology | ||||||
| 10/09/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Diabetes | ||||||
| 10/03/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Cardio-renal | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: RESPIRATORY | ||||||
| 09/15/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Diabetes | ||||||
| 09/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: RESPIRATORY | ||||||
| 08/31/2023 | Novavax Inc | NOVAVAX COVID-19 VACCINE, ADJUVANTED (Biological) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Vaccine | ||||||
| 08/18/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Vaccines | ||||||
| 08/15/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: INSOMNIA | ||||||
| 08/02/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Diabetes | ||||||
| 07/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Respiratory | ||||||
| 07/24/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 22 | $3,080 | $1,342 |
| 2022 | 2 | 44 | 64 | $10,780 | $4,153 |
| 2021 | 2 | 26 | 44 | $7,630 | $2,987 |
| 2020 | 1 | 19 | 31 | $4,340 | $1,762 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 22 | $3,080 | $1,342 | 43.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 38 | $5,320 | $2,092 | 39.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 26 | $5,460 | $2,061 | 37.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 21 | $4,410 | $1,695 | 38.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 23 | $3,220 | $1,292 | 40.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 19 | 31 | $4,340 | $1,762 | 40.6% |
About Samuel Waling
Samuel Waling is a Family Medicine healthcare provider based in Madison, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1053774018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Samuel Waling has received a total of $2,280 in payments from pharmaceutical and medical device companies, with $153.67 received in 2024. These payments were reported across 144 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,280).
As a Medicare-enrolled provider, Waling has provided services to 104 Medicare beneficiaries, totaling 161 services with total Medicare billing of $10,244. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Madison, AL
- Active Since 03/29/2016
- Last Updated 12/19/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1053774018
Products in Payments
- TRELEGY ELLIPTA (Drug) $578.58
- FARXIGA (Drug) $248.83
- Ozempic (Drug) $231.95
- Rybelsus (Drug) $177.21
- TRULICITY (Drug) $175.38
- Kerendia (Drug) $108.83
- JARDIANCE (Drug) $100.13
- XARELTO (Drug) $57.50
- MOUNJARO (Drug) $53.69
- GARDASIL 9 (Biological) $48.90
- PREVNAR 13 (Biological) $42.83
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $37.41
- MYRBETRIQ (Drug) $36.82
- FREESTYLE LIBRE 3 (Device) $35.52
- Azstarys (Drug) $33.48
- Otezla (Drug) $32.22
- STEGLATRO (Drug) $30.78
- SOLIQUA 100/33 (Biological) $29.61
- SHINGRIX (Biological) $28.72
- BREZTRI (Drug) $27.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Madison
Gary Johnson, Md, MD
Family Medicine — Payments: $301,766
Dr. Frederick Freitag, D.o, D.O
Family Medicine — Payments: $228,855
Michael Ostrov, Md, MD
Family Medicine — Payments: $160,148
Lewis Johnston, M.d, M.D
Family Medicine — Payments: $26,320
James Bigham, Md, MD
Family Medicine — Payments: $26,208
Dr. Peter Geleskie, M.d, M.D
Family Medicine — Payments: $22,887